• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Consumer Lawsuits Filed Against Anthem for Denying Harvoni Coverage

Article

Two lawsuits have been filed against Anthem Blue Cross for denying coverage to 2 women for the hepatitis C medication Harvoni.

Two lawsuits have been filed against Anthem Blue Cross for denying coverage to 2 women for the hepatitis C medication Harvoni. Both lawsuits claim the insurer denied coverage for Harvoni, because the amount of liver damage sustained by the women was insufficient to warrant payment for the drug, and the treatment was not medically necessary.

The arguments go back and forth. In its denial letter sent to 1 of the plaintiffs, Anthem said that the women's liver had not yet sustained enough damage. The plaintiff argues that preventing her liver from getting to that stage would be the point of her treatment.

Read the complete report on The Wall Street Journal: http://on.wsj.com/1FUq4Eu

Related Videos
Video 1 - "Diagnosing and Understanding the Pathogenesis of Bronchiectasis"
Video 4 - "Challenges in Autoantibody Screening for Type 1 Diabetes"
Jeff Stark, MD, vice president, head of medical immunology, UCB
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Video 6 - "Community Partnership: Increasing Public Awareness of CVD"
Video 6 - "Community Partnership: Increasing Public Awareness of CVD"
Screenshot of Raajit Rampal, MD, PhD
 Laura Ferris, MD, PhD, professor of dermatology, University of Pittsburgh
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.